Beyond interferon.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18066029.
- Also identified by PMC identifier 7096953.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Interferon (IFN)-α has reigned supreme for decades as biotech's blockbuster antiviral. That looks set to change with a raft of antibody and nucleic acid therapies progressing through the pipeline.
Medical subject headings
- Antibodies, Monoclonal
- Antiviral Agents
- Drug Design
- Drug Industry
- Interferon-alpha
- Pharmaceutical Preparations
- Vaccines, DNA